Loading
₹845.80
+9.40+1.12%today
Market closed · 7 Oct, 3:30 pm
+52.15%over 1 year
Today's range
₹822.20₹850.70
52-week range
₹529.85₹923.65
Revenue and net profit in ₹ crore, consolidated where the company reports both.
| Year | Revenue | Net profit | Margin | EPS (₹) |
|---|---|---|---|---|
| FY26 | 5,339 | 595 | 11.1% | 24.46 |
| FY25 | 4,456 | 502 | 11.3% | 20.68 |
| FY24 | 4,490 | 405 | 9.0% | 16.72 |
| FY23 | 4,496 | 517 | 11.5% | 21.00 |
As of Jun 2026, as a share of all the company's shares.
| Holder | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 38.02% | 38.02% | 38.82% | 38.82% |
| FIIs | 17.50% | 15.31% | 13.55% | 14.09% |
| DIIs | 16.11% | 17.01% | 17.48% | 17.92% |
| of which mutual funds | 3.45% | 2.85% | 5.35% | 6.54% |
| Public | 28.38% | 29.66% | 30.15% | 29.17% |
From the company's quarterly filings with NSE. FIIs are foreign institutions; DIIs are Indian ones such as mutual funds, insurers and banks.
Healthcare companies in the Nifty 500 closest in size.
| Company | Price (₹) | Change | Market cap (₹ cr) |
|---|---|---|---|
| Piramal Pharma Ltd.PPLPHARMA | 202.67 | +1.07% | 26,982 |
| Rubicon Research Ltd.RUBICON | 1,570.00 | −1.68% | 25,989 |
| Acutaas Chemicals Ltd.ACUTAAS | 3,168.60 | +0.38% | 25,942 |
| Granules India Ltd.GRANULES · this stock | 845.80 | +1.12% | 20,959 |
| Caplin Point Laboratories Ltd.CAPLIPOINT | 2,638.00 | −1.56% | 20,052 |
| Onesource Specialty Pharma Ltd.ONESOURCE | 1,530.00 | −0.38% | 17,545 |
| Cohance Lifesciences Ltd.COHANCE | 455.00 | −0.44% | 17,408 |
Price and volume from NSE; key figures and results from Yahoo Finance; shareholding and corporate actions from the company's NSE filings. Figures can run behind the exchange. For information only, not a recommendation to invest.